Lilly to acquire Kelonia Therapeutics for $3.25 billion to advance in vivo CAR-T cell therapies
On Apr. 20, 2026, Eli Lilly and Kelonia Therapeutics, a clinical-stage biotechnology company pioneering in vivo gene delivery,…
-
-
Biotechnology | Diagnostics | Medical Device | Medicine | Neurology | Non-Profit Research | Oncology | Pharmaceutical | Radiology | Therapeutics
Mass General Brigham Receives Transformative $50 Million Gift to Shape Future of Cancer Research
On Mar. 12, 2026, Mass General Brigham (MGB) announced it has received a $50 million gift that will…
-
Biotechnology | Disease | FDA | Non-Profit Research | Oncology | Radiology | Therapeutics
Siteman Cancer Center became one of the first cancer centers nationwide to offer newly approved CAR-T cell therapy called Yescarta
On Oct. 18, 2017, the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in…
